(Q37503831)

20 August 2017

1 reference

title

Should aldosterone blockade be used beyond current indications in heart failure? (English)

1 reference

20 August 2017

0 references

Dirk J van Veldhuisen

5

object named as

Dirk J van Veldhuisen

1 reference

20 August 2017

1

Marcelle D Smit

1 reference

20 August 2017

author name string

Isabelle C van Gelder

2

1 reference

20 August 2017

Michael Böhm

3

1 reference

20 August 2017

Hans-Ruprecht Neuberger

4

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Current heart failure reports

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

117-125

1 reference

Aldosterone induces a vascular inflammatory phenotype in the rat heart

20 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-009-0018-4

Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-009-0018-4

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11897-009-0018-4

Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure

21 January 2018

1 reference

12 December 2020

Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study

1 reference

12 December 2020

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

1 reference

12 December 2020

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

12 December 2020

Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?

1 reference

12 December 2020

Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart.

1 reference

12 December 2020

Candesartan in the prevention of relapsing atrial fibrillation

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure

1 reference

12 December 2020

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

12 December 2020

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

12 December 2020

Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm

1 reference

12 December 2020

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

1 reference

12 December 2020

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

12 December 2020

Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysis

1 reference

12 December 2020

Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats

1 reference

12 December 2020

Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction

1 reference

12 December 2020

The clinical implications of aldosterone escape in congestive heart failure.

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Management of atrial fibrillation in patients with heart failure

1 reference

12 December 2020

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

1 reference

12 December 2020

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment

1 reference

12 December 2020

Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation

1 reference

12 December 2020

Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats

1 reference

12 December 2020

Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts

1 reference

12 December 2020

Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction

1 reference

12 December 2020

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

1 reference

12 December 2020

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

12 December 2020

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

1 reference

12 December 2020

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

12 December 2020

Chronic beta-blocker treatment in patients with advanced heart failure

1 reference

12 December 2020

The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.

1 reference

12 December 2020

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Aldosterone blockade in post-acute myocardial infarction heart failure.

1 reference

12 December 2020

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

12 December 2020

Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure

1 reference

12 December 2020

10.1007/S11897-009-0018-4

Identifiers

DOI

1 reference

20 August 2017

1 reference